CD4 and melanoma: The results showed that the percentages and activation of CD8+ T cells and NK cells in the melanoma tissues were significantly increased after treatment with ssRNA and dual-function vectors (Figures 3A,B), whereas the proportions and activation of CD4+ T cells did not change (Figure 3C).